{
    "K143467.txt": {
        "device_name": "FORA GD43 Blood Glucose Monitoring System",
        "intended_use": "The FORA GD43 Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose (sugar) in fresh capillary whole blood from the fingertip and alternative sites (palm, forearm and upper arm).",
        "device_type": "Blood Glucose Monitoring System",
        "analytical_specificity": "The sponsor has the following limitations in their labeling: \u00b7 Exogenous substances: Dopamine, L-Dopa, methyldopa, tolazamide, ascorbic acid (vitamin C), acetaminophen and mannose may cause inaccurate results if concentrations of these substances is greater than therapeutic/physiologic concentrations.",
        "classification": "Class II",
        "detection_limit": "20 to 600 mg/dL",
        "assay_cut_off": "Not Applicable",
        "predicate_device_name": "FORA GD40 Blood Glucose Monitoring System",
        "measurand": "Capillary whole blood glucose from the fingertip, palm, forearm, and upper arm"
    },
    "K171742.txt": {
        "device_name": "N Latex FLC Kappa assay",
        "intended_use": "In-vitro diagnostic reagents for the quantitative determination of free light chains (FLC), type kappa or type lambda in human serum and EDTA-plasma by means of particle-enhanced immunonephelometry using the BN Systems.",
        "device_type": "Class II, test systems",
        "analytical_specificity": "No interferences were observed with the following tabulated lists of endogenous and exogenous substances with their corresponding concentration labels as shown below:",
        "classification": "Class II, test systems",
        "detection_limit": "0.195 mg/L for FLC Kappa and 0.532 mg/L for FLC Lambda",
        "assay_cut_off": "See expected values/reference range",
        "predicate_device_name": "The Binding Site Freelite Human Kappa Free Kit for use on the Siemens BN II",
        "measurand": "Kappa (\u03ba) Free Light Chain (FLC) and Lambda (\u03bb) Free Light Chain (FLC)",
        "panel": "Immunology (82)"
    },
    "K170491.txt": {
        "device_name": "Solana C. difficile Assay",
        "intended_use": "The Solana C. difficile assay is an in vitro diagnostic test for the direct, qualitative detection of the Clostridium difficile Toxin A gene (tcdA) in unformed stool specimens of patients suspected of having Clostridium difficile infection (CDI). The Solana C. difficile assay is intended for use as an aid in diagnosis of CDI.",
        "device_type": "Qualitative Helicase-Dependent Amplification (HDA) assay",
        "analytical_specificity": "No cross reactivity or microbial interference was observed with any of the wet tested panel members.",
        "classification": "II",
        "detection_limit": "The Limit of Detection (LoD) of the Solana C. difficile Assay was determined using serial dilutions of two toxigenic C. difficile strains, ATCC BAA\u20131805 and CCUG 20309 spiked in negative stool matrix.",
        "assay_cut_off": "The cut-off values for the Solana C. difficile Assay were based on specific parameters of the amplification curve calculated from results from preliminary LoD studies and initial clinical specimen testing.",
        "predicate_device_name": "Portrait Toxigenic C. difficile Assay",
        "measurand": "tcdA gene of toxigenic Clostridium difficile",
        "panel": "Microbiology (83)"
    },
    "K161220.txt": {
        "device_name": "ARIES Flu A/B & RSV Assay",
        "intended_use": "The ARIES Flu A/B & RSV Assay is a polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection and differentiation of influenza A virus, influenza B virus, and respiratory syncytial virus (RSV) nucleic acid in nasopharyngeal swab (NPS) specimens from patients with signs and symptoms of respiratory tract infection in conjunction with clinical and laboratory findings.",
        "device_type": "In vitro diagnostic test system",
        "analytical_specificity": "The ARIES Flu A/B and RSV Assay does not cross-react with any of the 32 common respiratory microorganisms tested.",
        "classification": "Class II",
        "detection_limit": "The Limit of Detection (LoD) was established for the ARIES Flu A/B & RSV Assay using three influenza A, two influenza B, and two respiratory syncytial virus strains diluted in a simulated nasal matrix.",
        "assay_cut_off": "Each target (influenza A, Influenza B, RSV and sample processing control) has its own Ct cut-off value, Tm window, and Tm Peak Threshold, all of which are used to determine the assay result for the detection target as positive or negative.",
        "predicate_device_name": "Simplexa Flu A/B & RSV Direct",
        "measurand": "Influenza A RNA:  Matrix gene, Influenza B RNA:  Matrix gene, Respiratory Syncytial Virus (RSV) RNA: Fusion gene of RSV A and RSV B",
        "panel": "Microbiology (83)"
    },
    "K172913.txt": {
        "device_name": "cobas Factor II and Factor V Test",
        "intended_use": "The cobas Factor II and Factor V Test is an in vitro diagnostic device that uses real-time PCR for the detection and genotyping of the Factor II (Prothrombin) G20210A mutation and the Factor V Leiden G1691A mutation in genomic DNA obtained from K2EDTA whole blood specimens as an aid in diagnosis of patients with suspected thrombophilia.",
        "device_type": "Genotyping test",
        "analytical_specificity": "The cobas Factor II and Factor V Test did not interfere with the presence of triglycerides, bilirubin, cholesterol, and hemoglobin, K2EDTA, heparin, warfarin (Coumadin), rivaroxaban (Xarelto), and dabigatran etexilate (Pradaxa).",
        "classification": "Class II",
        "detection_limit": "0.01 ng/\u00b5L",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Roche Factor II (Prothrombin) G20210A Kit, Roche Factor V Leiden Kit",
        "measurand": "Factor II and Factor V",
        "panel": "Hematology (81)"
    },
    "K160082.txt": {
        "device_name": "Puritan Opti-Tranz Cary-Blair Collection and Transport System",
        "intended_use": "collection and transport of clinical fecal and rectal swab specimens to preserve the viability of enteric bacteria during transport from the collection site to the testing laboratory for bacteriological examination and culture",
        "device_type": "Collection and transport culture medium device",
        "analytical_specificity": "Not applicable",
        "classification": "Class I",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Copan Venturi Transystem Cary-Blair Medium product (132C)",
        "measurand": "Not applicable",
        "panel": "83- Microbiology"
    },
    "K180886.txt": {
        "device_name": "Liofilchem MIC Test Strip (MTS)",
        "intended_use": "The Liofilchem MIC Test Strip (MTS) is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of bacteria.",
        "device_type": "Quantitative Antimicrobial Susceptibility Test growth based detection",
        "analytical_specificity": "Not Applicable",
        "classification": "II",
        "detection_limit": "Not Applicable",
        "assay_cut_off": "Not Applicable",
        "predicate_device_name": "Liofilchem MTS, vancomycin",
        "measurand": "Delafloxacin 0.002-32 \u03bcg/mL",
        "panel": "83 \u2013 Microbiology"
    },
    "K153278.txt": {
        "device_name": "iHealth Wireless Smart Gluco-Monitoring System (BG5)",
        "intended_use": "The iHealth Wireless Gluco-Monitoring System is intended to be used for the quantitative measurement of glucose (sugar) in fresh capillary whole blood samples drawn from the fingertip, palm, forearm, upper arm, calf, or thigh.",
        "device_type": "Quantitative, amperometric assay, glucose oxidase",
        "analytical_specificity": "As established in k110017.",
        "classification": "II",
        "detection_limit": "As established in k110017.",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "iHealth BG5 Wireless Smart Gluco-Monitoring System",
        "measurand": "Capillary Whole Blood Glucose",
        "panel": "21 \u00a7 862.1345 Glucose test system"
    },
    "K181525.txt": {
        "device_name": "INNOVANCE Free PS Ag",
        "intended_use": "For the quantitative determination of free protein S antigen in human plasma collected from venous blood samples in 3.2% sodium citrate tubes on the Sysmex CS- 5100 analyzer. As an aid in the diagnosis of protein S deficiency in patients who are suspected of free protein S deficiency.",
        "device_type": "Quantitative immunoturbidimetric assay",
        "analytical_specificity": "The following common endogenous and exogenous interfering substances were evaluated and showed no significant interference up to the specified concentration in citrated plasma samples.",
        "classification": "Class II",
        "detection_limit": "1.2%",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "STA-Liatest Free Protein S",
        "measurand": "Free Protein S Antigen (%)",
        "panel": "Hematology (81)"
    },
    "K190223.txt": {
        "device_name": "Cepheid Xpert CT/NG Control Panel",
        "intended_use": "The Cepheid Xpert CT/NG Control Panel is intended for use as an external assayed positive and negative quality control to monitor the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) performed with the Cepheid Xpert CT/NG assay on the GeneXpert Instrument System.",
        "device_type": "Assayed external control material for microbiology nucleic acid amplification assays",
        "analytical_specificity": "Not applicable",
        "classification": "Class II (Special Controls)",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Cepheid Xpert GBS LB Control Panel",
        "measurand": "Nucleic acids from inactivated Chlamydia trachomatis and Neisseria gonorrhoeae (positive control) and from human epithelial cells (negative control)",
        "panel": "Microbiology"
    },
    "K162042.txt": {
        "device_name": "OptiScanner 5000 Glucose Monitoring System",
        "intended_use": "detecting trends and tracking patterns in persons (age 18 and older) in the surgical intensive care unit",
        "device_type": "Pump, Infusion",
        "analytical_specificity": "Fifty-two endogenous and exogenous substances were evaluated in a bench study to determine the effect of potentially interfering compounds on device performance",
        "classification": "LZF",
        "detection_limit": "See linearity study in Section M.1.b. above",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "VIA Medical Corp Pump/Blood Chemistry Monitor",
        "measurand": "Plasma glucose from central venous catheter blood draw",
        "panel": "Clinical Chemistry"
    },
    "K171770.txt": {
        "device_name": "cobas Liat System",
        "intended_use": "The cobas Cdiff Nucleic acid test for use on the cobas Liat System is an automated, qualitative in vitro diagnostic test, that utilizes real-time polymerase chain reaction (PCR), for the detection of the toxin B (tcdB) gene of toxigenic Clostridium difficile in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI).",
        "device_type": "Real-time PCR assay",
        "analytical_specificity": "No wet testing was conducted for Clostridium botulinum; analytical specificity for this organism was predicted using BLAST program analysis against the GenBank nucleotide sequence database to mimic PCR amplicon generation.",
        "classification": "II",
        "detection_limit": "The Limit of Detection (LoD) for the cobas Liat Cdiff test was determined by analyzing quantified C. difficile cultures diluted to multiple concentration levels in negative stool matrix.",
        "assay_cut_off": "Data from pre-clinical testing of stool specimens were compiled and analyzed to verify the preliminary cut-off value.",
        "predicate_device_name": "cobas Cdiff Test for use on the cobas 4800 System",
        "measurand": "tcdB gene of toxigenic Clostridium difficile",
        "panel": "Microbiology (83)"
    },
    "K171641.txt": {
        "device_name": "Accula Flu A/Flu B Test",
        "intended_use": "The Accula Flu A/Flu B Test performed on the Accula Dock is a molecular in vitro diagnostic test utilizing polymerase chain reaction (PCR) and lateral flow technologies for the qualitative, visual detection and differentiation of influenza A and influenza B viral RNA.",
        "device_type": "RT-PCR amplification followed by hybridization and colorimetric visualization of amplified products on a test strip",
        "analytical_specificity": "No cross-reactivity was observed for any of the microorganisms tested.",
        "classification": "Class II",
        "detection_limit": "The final concentrations whereby at least 95% of results (\u226519/20) were positive for the target virus are shown in the table below:",
        "assay_cut_off": "Not applicable; the detection signal is read visually.",
        "predicate_device_name": "Alere i Influenza A&B",
        "measurand": "Influenza A PB2 RNA Influenza B Matrix RNA",
        "panel": "Microbiology (83)"
    },
    "K180559.txt": {
        "device_name": "HSV 1&2 ELITe MGB Assay",
        "intended_use": "The HSV 1&2 ELITe MGB Assay is a real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection and differentiation of Herpes Simplex Virus 1 and 2 (HSV-1 and HSV-2) DNA in cutaneous or mucocutaneous lesion swab specimens from patients with signs and symptoms of HSV-1 or HSV-2 infection.",
        "device_type": "Qualitative Real-Time PCR Assay",
        "analytical_specificity": "The analytical reactivity (Inclusivity) of the HSV 1&2 ELITe MGB Assay was tested on 44 well characterized commercially available HSV-1 and HSV-2 isolates.",
        "classification": "Class II",
        "detection_limit": "The limit of detection (LoD) of the HSV 1&2 ELITe MGB Assay was determined using 4 HSV strains (two for each target). Quantitated viral strains were obtained and serially diluted into HSV negative pooled human oral cheek matrix in UTM.",
        "assay_cut_off": "CT of 45 was established as a diagnostic assay cut-off for both HSV-1 and HSV-2 targets.",
        "predicate_device_name": "ARIES HSV 1&2 Assay",
        "measurand": "Target DNA Sequences from conserved regions of Herpes Simplex Virus Type 1 (HSV-1) and Herpes Simplex Virus Type 2 (HSV-2)",
        "panel": "83 - Microbiology"
    },
    "K160538.txt": {
        "device_name": "Sysmex XN-L Automated Hematology Analyzer",
        "intended_use": "in vitro diagnostic use in screening patient populations found in clinical laboratories",
        "device_type": "quantitative multi-parameter automated hematology analyzer",
        "analytical_specificity": "whole blood and body fluids",
        "classification": "Class II",
        "detection_limit": "0.01 x 103/\u03bcL for WBC, 0.00 x 106/\u03bcL for RBC, 0.0 g/dL for HGB, 0.0 % for HCT, 0 x 103/\u03bcL for PLT",
        "assay_cut_off": "0.03 x 103/\u03bcL for WBC, 0.00 x 106/\u03bcL for RBC, 0.0 g/dL for HGB, 0.0 % for HCT, 1 x 103/\u03bcL for PLT",
        "predicate_device_name": "Sysmex XN-Series (XN-10, XN-20) Automated Hematology Analyzer",
        "measurand": "WBC, RBC, HGB, HCT, MCV, MCH, MCHC, PLT, NEUT%/#, LYMPH%/#, MONO%/#, EO%/#, BASO%/#, IG%/#, RDW-CV, RDW-SD, MPV, RET%/#, IRF, RET-He",
        "panel": "Hematology (81)"
    },
    "K151923.txt": {
        "device_name": "VITEK 2 AST-Yeast Micafungin",
        "intended_use": "antifungal susceptibility testing of Candida species",
        "device_type": "Automated quantitative or qualitative antifungal susceptibility test",
        "analytical_specificity": "Not applicable",
        "classification": "II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "VITEK 2 AST-YS Flucytosine",
        "measurand": "The VITEK 2 AST Yeast card contains the following concentration of Micafungin: 0.06, 0.25, 1 and 4\u03bcg/mL",
        "panel": "83 Microbiology"
    },
    "K182472.txt": {
        "device_name": "Cepheid Xpert GBS LB Control Panel",
        "intended_use": "External assayed positive and negative quality control materials to monitor the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of Group B Streptococcus (GBS) performed with the Cepheid Xpert GBS LB Assay on the GeneXpert Instrument System.",
        "device_type": "Assayed Microbiology Control",
        "analytical_specificity": "Not applicable.",
        "classification": "Class II (Special Controls)",
        "detection_limit": "Not applicable.",
        "assay_cut_off": "Not applicable.",
        "predicate_device_name": "Bio-Rad Amplichek II",
        "measurand": "Nucleic acid quality control material from inactivated Streptococcus agalactiae and Lactobacillus acidophilus bacterial cultures for detection of Streptococcus agalactiae (Group B Streptococcus positive control) and Lactobacillus acidophilus (negative control).",
        "panel": "83 - Microbiology"
    },
    "K162688.txt": {
        "device_name": "Sysmex CS-2100i",
        "intended_use": "The Sysmex CS-2100i is a fully automated blood coagulation analyzer intended for in vitro diagnostic use using plasma collected from venous blood samples in 3.2% sodium citrate tubes to analyze clotting, chromogenic and immunoassay methods in the clinical laboratory.",
        "device_type": "Device",
        "analytical_specificity": "No significant interference was observed up to the following interferent concentrations.",
        "classification": "Class II",
        "detection_limit": "The limit of quantitation (LoQ) was established for each assay.",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Sysmex Automated Coagulation Analyzer CA-1500",
        "measurand": "Factor V activity using Coagulation Factor V Deficient Plasman with Dade Innovin; factor VII activity using Coagulation Factor VII Deficient Plasma with Dade Innovin; protein C activity using Protein C Reagent and protein C activity using Berichrom Protein C."
    },
    "K190332.txt": {
        "device_name": "Aperio AT2 DX System",
        "intended_use": "The Aperio AT2 DX System is an automated digital slide creation and viewing system. The Aperio AT2 DX System is intended for in vitro diagnostic use as an aid to the pathologist to review and interpret digital images of surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue.",
        "device_type": "Whole Slide Imaging (WSI) system",
        "analytical_specificity": "Not applicable",
        "classification": "Class II (special controls)",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Philips IntelliSite Pathology Solution (PIPS)",
        "measurand": "Not applicable",
        "panel": "88 - Pathology"
    },
    "K151046.txt": {
        "device_name": "illumigene HSV 1&2 DNA Amplification Assay",
        "intended_use": "The illumigene HSV 1&2 DNA amplification assay, performed on the illumipro-10, is a qualitative in vitro diagnostic test for the direct detection and differentiation of herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) DNA in cutaneous and mucocutaneous lesion specimens from male and female patients suspected of Herpetic infections.",
        "device_type": "Qualitative in vitro diagnostic device",
        "analytical_specificity": "The illumigene HSV 1&2 DNA Amplification Assay is specific for the detection of HSV-1 and HSV-2 DNA.",
        "classification": "Class II",
        "detection_limit": "9.89 x 104 TCID50/mL for HSV-1 and 1.60 x 103 TCID50/mL for HSV-2",
        "assay_cut_off": "Fixed cut-off values are applied as described in the Device Description section.",
        "predicate_device_name": "Lyra Direct HSV 1 + 2/VZV assay (Quidel Corporation)",
        "measurand": "Target DNA sequences from Herpes Simplex Virus type 1 (HSV-1) and Herpes Simplex Virus type 2 (HSV-2)",
        "panel": "Microbiology (83)"
    },
    "K172333.txt": {
        "device_name": "Sysmex CS-5100",
        "intended_use": "The Sysmex CS-5100 is a fully automated blood coagulation analyzer intended for in vitro diagnostic use using plasma collected from venous blood samples in 3.2% sodium citrate tubes to analyze clotting, chromogenic and immunoassay methods in the clinical laboratory.",
        "device_type": "Device",
        "analytical_specificity": "No significant interference was observed up to the following interferent concentrations.",
        "classification": "Class II:  Factor V Leiden Assay; Coagulation Factor VIII Deficient Plasma; Coagulation Factor IX Deficient Plasma Class I:  LA 1 Screening Reagent, LA 2 Confirmation Reagent, and LA Ratio",
        "detection_limit": "The Factor V Leiden and Lupus Anticoagulant assays are non-calibrated clotting-based assays for which there is no detection limit.",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Sysmex CA-1500",
        "measurand": "Factor V Leiden activity with Factor V Leiden Assay; Factor VIII activity with Dade Actin FSL Activated PTT Reagent; Factor IX activity with Dade Actin FSL Activated PTT Reagent; Lupus Anticoagulant with LA 1 Screening Reagent; Lupus Anticoagulant with LA 2 Confirmation Reagent and Lupus Anticoagulant with LA Ratio"
    },
    "K152614.txt": {
        "device_name": "Xpert Carba-R Assay",
        "intended_use": "qualitative in vitro diagnostic test for the detection and differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48, and blaIMP gene sequences associated with carbapenem-non-susceptible pure colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa grown on blood agar or MacConkey agar",
        "device_type": "Qualitative real-time polymerase chain reaction (PCR) assay",
        "analytical_specificity": "The Xpert Carba-R Assay was examined for analytical specificity by testing a panel of 62 well-characterized carbapenem-susceptible bacteria or bacteria with carbapenem non-susceptibility due to genes or mechanisms other than the Xpert Carba-R target genes",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "A Ct value outside the valid range is reported as NOT DETECTED",
        "predicate_device_name": "Cepheid Xpert vanA Assay",
        "measurand": "Target DNA sequence of the following genes: blaKPC, blaNDM, blaVIM, blaOXA-48, and blaIMP",
        "panel": "83-Microbiology"
    },
    "K143736.txt": {
        "device_name": "ImmuLisa Enhanced",
        "intended_use": "aid in the diagnosis of rheumatoid arthritis (RA) in conjunction with other laboratory tests and clinical findings",
        "device_type": "ELISA",
        "analytical_specificity": "Endogenous interference: Triglycerides and bilirubin interfered (\u226515% in at least two of five samples) with the RF IgM assay at the concentrations tested.",
        "classification": "Class II",
        "detection_limit": "3.2 EU/mL for IgA, 1.5 EU/mL for IgG, 1.2 IU/mL for IgM",
        "assay_cut_off": "20 EU/mL for IgA, IgG, and IgA/IgG/IgM ELISAs, 10 IU/mL for IgM ELISA",
        "predicate_device_name": "Inova QuantaLite",
        "measurand": "Rheumatoid Factors (RF) IgA, IgG, IgM, and Rheumatoid Factor Total",
        "panel": "Immunology (82)"
    },
    "K162705.txt": {
        "device_name": "VALIDATE D-Dimer Calibration Verification/Linearity Test Kit",
        "intended_use": "in vitro diagnostic use in the quantitative determination of linearity, calibration verification and verification of reportable range for the following analyte: D-Dimer in a clinical laboratory setting by laboratory personnel",
        "device_type": "Quantitative",
        "analytical_specificity": "Not applicable",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "VALIDATE D-Dimer Calibration Verification/Linearity Test Kit",
        "measurand": "D-dimer",
        "panel": "Hematology (81)"
    },
    "K192815.txt": {
        "device_name": "Elecsys BRAHMS PCT",
        "intended_use": "Immunoassay for the in vitro quantitative determination of PCT (procalcitonin) in human serum and plasma (K2 \u2013EDTA, K3-EDTA and Li-Heparin).",
        "device_type": "Quantitative, Electrochemiluminescence Immunoassay",
        "analytical_specificity": "The specificity of the Elecsys BRAHMS PCT was determined using native human serum samples spiked with potential cross-reactant compounds.",
        "classification": "Class II",
        "detection_limit": "0.025 ng/mL",
        "assay_cut_off": "28-day mortality: \u2022 \u0394PCT \u2264 80% A decrease in the PCT levels below or equal to 80% defines a positive \u0394PCT test result representing a higher risk for 28-day all-cause mortality of patients diagnosed with severe sepsis or septic shock.",
        "predicate_device_name": "Elecsys BRAHMS PCT",
        "measurand": "Procalcitonin (PCT)",
        "panel": "Microbiology"
    },
    "K183324.txt": {
        "device_name": "Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Omadacycline",
        "intended_use": "The Sensititre Haemophilus influenzae/Streptococcus pneumoniae plates are in vitro diagnostic products for clinical susceptibility testing of Haemophilus influenzae, Streptococcus pneumoniae, and Streptococcus species.",
        "device_type": "Quantitative Antimicrobial Susceptibility Test (AST), growth-based detection",
        "analytical_specificity": "Not applicable",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Sensititre Haemophilus/Streptococcus pneumoniae (HP) MIC Plates",
        "measurand": "Omadacycline in the dilution range of 0.008 \u2013 32 \u00b5g/mL",
        "panel": "83, Microbiology"
    },
    "K172745.txt": {
        "device_name": "ImmuGlo HEp-2 Elite IFA",
        "intended_use": "The ImmuGlo HEp-2 Elite IFA is an indirect immunofluorescence antibody test for the qualitative or semi-quantitative detection of anti-nuclear antibodies (ANA) of the IgG isotype in human serum utilizing standard HEp-2 cells and engineered HEp-2 cells as a substrate.",
        "device_type": "Indirect immunofluorescence antibody test",
        "analytical_specificity": "The assay cutoff of 1:40 was established from literature. The recommended screening dilution is 1:40, at which a result with fluorescence intensity 1+ \u2013 4+ and a recognizeable pattern is reported as positive.",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "1:40",
        "predicate_device_name": "ImmuGlo ANTINUCLEAR ANTIBODY (ANA) TEST (HEP-2) CELLS",
        "measurand": "IgG Anti-Nuclear Antibodies (ANA)",
        "panel": "Immunology (82)"
    },
    "K161510.txt": {
        "device_name": "VITEK 2 AST-GN Ceftolozane/Tazobactam",
        "intended_use": "The VITEK 2 Antimicrobial Susceptibility Test (AST) is intended to be used with the VITEK 2 Systems for the automated quantitative or qualitative susceptibility testing of isolated colonies for the most clinically significant aerobic gram-negative bacilli, Staphylococcus spp., Enterococcus spp., Streptococcus spp. and clinically significant yeast.",
        "device_type": "Automated quantitative or qualitative antimicrobial susceptibility test for Ceftolozane/Tazobactam",
        "analytical_specificity": "Not applicable",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "VITEK 2 AST-GN Doxycycline",
        "measurand": "The VITEK 2 AST-GN Ceftolozane/Tazobactam has the following concentrations in the card: 0.5/4, 1/4, 4/4, 8/4, and 32/4\u00b5g/mL (equivalent standard method concentration by efficacy in \u00b5g/mL). The MIC result range for the VITEK 2 card is \u22640.25 - \u226532 \u00b5g/mL.",
        "panel": "Microbiology (83)"
    },
    "K181915.txt": {
        "device_name": "PixoTest POCT System",
        "intended_use": "monitor long term glycemic control in individuals previously diagnosed with diabetes mellitus",
        "device_type": "Analyzer, Chemistry (Photometric, Discrete), For Clinical Use",
        "analytical_specificity": "Endogenous and exogenous substances were spiked at two levels into each of two K2-EDTA venous whole blood samples (containing approximately 5.5% or 9.6% HbA1c).",
        "classification": "Hematology (81)",
        "detection_limit": "4.0-15.0% HbA1c",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "SD A1cCare System",
        "measurand": "Glycosylated hemoglobin (HbA1c)"
    },
    "K182389.txt": {
        "device_name": "Sysmex XN-L Automated Hematology Analyzer",
        "intended_use": "in vitro diagnostic use in screening patient populations found in clinical laboratories",
        "device_type": "quantitative multi-parameter automated hematology analyzer",
        "analytical_specificity": "classifies and enumerates whole blood and body fluid parameters by means of electrical impedance, laser light scattering, and fluorescent labeling",
        "classification": "Class II",
        "detection_limit": "not available",
        "assay_cut_off": "not available",
        "predicate_device_name": "Sysmex XN-Series (XN-10, XN-20) Automated Hematology Analyzer",
        "measurand": "WBC, RBC, HGB, HCT, MCV, MCH, MCHC, PLT, NEUT%/#, LYMPH%/#, MONO%/#, EO%/#, BASO%/#, IG%/#, RDW-CV, RDW-SD, MPV, RET%/#, IRF, RET-He and has a Body Fluid mode for body fluids",
        "panel": "Hematology (81)"
    },
    "K183415.txt": {
        "device_name": "VITEK 2 AST-GN Imipenem",
        "intended_use": "antimicrobial susceptibility testing of Gram negative bacilli and is intended for use with the VITEK 2 and VITEK 2 Compact Systems as a laboratory aid in the determination of in vitro susceptibility to antimicrobial agents",
        "device_type": "Automated quantitative antimicrobial susceptibility (AST)",
        "analytical_specificity": "N/A",
        "classification": "Class II",
        "detection_limit": "N/A",
        "assay_cut_off": "N/A",
        "predicate_device_name": "VITEK 2 AST-GN Amikacin",
        "measurand": "Imipenem 0.25 \u2013 16 \u00b5g/mL"
    },
    "K173927.txt": {
        "device_name": "Elecsys BRAHMS PCT",
        "intended_use": "Immunoassay for the in vitro quantitative determination of PCT (procalcitonin) in human serum and plasma (K2 \u2013EDTA, K3-EDTA and Li-Heparin).",
        "device_type": "Quantitative, Electrochemiluminescence Immunoassay",
        "analytical_specificity": "The Elecsys BRAHMS PCT assay on Elecsys and cobas e analyzers does not show any significant cross-reaction with the following substances, tested with PCT concentrations of approximately 0.4 ng/mL and 1.5 ng/mL (maximum tested concentration):",
        "classification": "Class II (Special Controls)",
        "detection_limit": "0.02 ng/mL",
        "assay_cut_off": "28-day mortality: \u00b7 \u0394PCT \u2264 80%",
        "predicate_device_name": "BRAHMS PCT sensitive KRYPTOR",
        "measurand": "Procalcitonin (PCT)"
    },
    "K172109.txt": {
        "device_name": "Liofilchem MIC Test Strip (MTS)",
        "intended_use": "The Liofilchem MIC Test Strip (MTS) is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of bacteria.",
        "device_type": "Quantitative AST growth based detection",
        "analytical_specificity": "Not Applicable",
        "classification": "II",
        "detection_limit": "Not Applicable",
        "assay_cut_off": "Not Applicable",
        "predicate_device_name": "Liofilchem MTS, vancomycin",
        "measurand": "Erythromycin 0.016-256 \u03bcg/mL",
        "panel": "83 \u2013 Microbiology"
    },
    "K150617.txt": {
        "device_name": "cobas HSV 1 and 2 Test",
        "intended_use": "aid in diagnosis of anogenital HSV-1 and HSV-2 infections in symptomatic patients",
        "device_type": "automated, qualitative in vitro diagnostic test",
        "analytical_specificity": "no cross reactivity with other microorganisms",
        "classification": "Class II",
        "detection_limit": "0.479 TCID50/mL for HSV-1 and 0.112 TCID50/mL for HSV-2",
        "assay_cut_off": "N/A",
        "predicate_device_name": "BD ProbeTecTM Herpes Simplex Viruses (HSV 1 & 2) Qx Amplified DNA Assays",
        "measurand": "Target DNA sequences from Herpes Simplex Virus type 1 (HSV-1) and Herpes Simplex Virus type 2 (HSV-2)",
        "panel": "Microbiology (83)"
    },
    "K151767.txt": {
        "device_name": "Trinidad CH System",
        "intended_use": "The Trinidad CH System is an automated, clinical chemistry analyzer designed to perform in vitro diagnostic tests on clinical specimens.",
        "device_type": "Floor model, fully automated, microprocessor-controlled, integrated instrument system",
        "analytical_specificity": "Interference studies were performed according to CLSI EP-7A guidance to determine the effects from potential interferents on the ISE and albumin assays.",
        "classification": "Class II",
        "detection_limit": "The Limit of Blank (LoB), Limit of Detection (LoD) and Limit of Quantification (LoQ) were evaluated in accordance with CLSI EP17-A2 Guideline.",
        "assay_cut_off": "Not Applicable",
        "predicate_device_name": "Siemens ADVIA 1800 Chemistry System",
        "measurand": "Sodium, Potassium, Chloride, Albumin"
    },
    "K150144.txt": {
        "device_name": "VisuCon-F Low Fibrinogen Control Plasma",
        "intended_use": "The VisuCon-F Low Fibrinogen Control Plasma is an assayed control plasma prepared from de-fibrinated human plasma intended for use in the quality control of quantitative fibrinogen assays in the low abnormal range.",
        "device_type": "Plasma, Coagulation Control",
        "analytical_specificity": "Not applicable",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Cryocheck Low Fibrinogen Control",
        "measurand": "Fibrinogen",
        "panel": "81 (Hematology)"
    },
    "K153137.txt": {
        "device_name": "HemosIL HIT-Ab(PF4-H)",
        "intended_use": "qualitative, fully automated, latex enhanced immunoassay for the detection of anti-platelet factor 4/heparin (PF4/H) antibodies",
        "device_type": "latex particle enhanced immuno-turbidimetric assay",
        "analytical_specificity": "analytical specificity for detecting anti-HIT antibodies was tested using 10 \u03bcL of PF4/ Heparin complex to inhibit reactivity of the assay in 18 citrated patient plasma samples",
        "classification": "Class II",
        "detection_limit": "0.2U/mL",
        "assay_cut_off": "1.0 U/mL",
        "predicate_device_name": "Asserachrom HPIA Test Kit",
        "measurand": "Anti-PF4/Heparin Total Antibodies",
        "panel": "Hematology (81)"
    },
    "K170127.txt": {
        "device_name": "HardyDisk Ceftolozane/Tazobactam, (30/10\u00b5g) - C/T40",
        "intended_use": "HardyDisk AST Disks are used for semi-quantitative in vitro susceptibility testing by the agar diffusion test procedure (Kirby-Bauer) of rapidly growing and certain fastidious bacterial pathogens.",
        "device_type": "Antimicrobial Susceptibility Test Disks",
        "analytical_specificity": "Not applicable",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "HardyDisk Tigecycline",
        "measurand": "Ceftolozane/Tazobactam, 30/10\u00b5g",
        "panel": "83 - Microbiology"
    },
    "K143548.txt": {
        "device_name": "TRUE METRIX GO Blood Glucose Monitoring System",
        "intended_use": "quantitative measurement of glucose (sugar) in fresh capillary whole blood samples drawn from the fingertip",
        "device_type": "Blood Glucose Monitoring System",
        "analytical_specificity": "The sponsor defines no significant interference as \u2264 \u00b110 % difference relative to the control sample",
        "classification": "Class II",
        "detection_limit": "20-600 mg/dL",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Bayer Ascensia Contour Blood Glucose Monitoring System",
        "measurand": "Capillary whole blood glucose from the fingertip",
        "panel": "Clinical Chemistry (75)"
    },
    "K163517.txt": {
        "device_name": "Liofilchem MIC Test Strip (MTS)",
        "intended_use": "The Liofilchem MIC Test Strip (MTS) is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of non-fastidious Gram negative and Gram positive aerobic bacteria (for example, Enterobacteriaceae, Pseudomonas, Enterococcus and Staphylococcus species) and fastidious bacteria (for example, anaerobes, Haemophilus and Streptococcus species and N. gonorrhoeae).",
        "device_type": "Quantitative AST growth based detection",
        "analytical_specificity": "Not applicable",
        "classification": "II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Liofilchem MIC Test Strip (MTS) \u2013 Vancomycin 0.016 \u2013 256 \u03bcg/mL",
        "measurand": "Telavancin 0.016 \u2013 256 \u00b5g/mL",
        "panel": "2 83 \u2013 Microbiology"
    },
    "K152495.txt": {
        "device_name": "Wondfo Propoxyphene Urine Test",
        "intended_use": "The Wondfo Propoxyphene Urine Test is an immunochromatographic assay for the qualitative determination of d-Propoxyphene in human urine at a cutoff concentration of 300 ng/mL.",
        "device_type": "Qualitative immunochromatographic assay",
        "analytical_specificity": "See k121557",
        "classification": "Class II",
        "detection_limit": "See k121557",
        "assay_cut_off": "300 ng/mL",
        "predicate_device_name": "Wondfo Propoxyphene Urine Test",
        "measurand": "Propoxyphene",
        "panel": "Toxicology, 91"
    },
    "K181324.txt": {
        "device_name": "FilmArray Pneumonia Panel plus",
        "intended_use": "multiplexed nucleic acid test intended for use with FilmArray, FilmArray 2.0, or FilmArray Torch systems for the simultaneous detection and identification of multiple respiratory viral and bacterial nucleic acids, as well as select antimicrobial resistance genes, in sputum-like specimens (induced or expectorated sputum, or endotracheal aspirates) or bronchoalveolar lavage (BAL)-like specimens (BAL or mini-BAL) obtained from individuals meeting MERS-CoV clinical and/or epidemiological criteria",
        "device_type": "multiplex nucleic acid test",
        "analytical_specificity": "qualitative and quantitative nucleic acid amplification assay",
        "classification": "Class II (Special Controls)",
        "detection_limit": "limit of detection (LoD) was established for MERS-CoV as well as atypical bacteria and viruses detected by the FilmArray Pneumonia Panel plus",
        "assay_cut_off": "assay-specific LoD concentrations were not determined for the bacterial analytes, however, each assay was determined to be linear (slope \u2248 1.0 and coefficient of determination (Adj R2) >0.95) and estimates of nucleic acid abundance were determined to be accurate within 0.5 log10 copies/mL when compared to an input concentration determined by digital PCR",
        "predicate_device_name": "FilmArray Respiratory Panel 2 plus (RP2plus)",
        "measurand": "nucleic acids from Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and multiple respiratory viral and bacterial nucleic acids, as well as select antimicrobial resistance genes",
        "panel": "83-Microbiology"
    },
    "K162840.txt": {
        "device_name": "Elecsys Vitamin D total II",
        "intended_use": "the quantitative determination of total 25-hydroxyvitamin D in human serum and plasma. This assay is to be used as an aid in the assessment of vitamin D sufficiency in adults.",
        "device_type": "Assay Only Template",
        "analytical_specificity": "The Elecsys Vitamin D total II assay employs a competitive protein binding assay which uses Vitamin D Binding Protein for detection of 25-OH Vitamin D.",
        "classification": "Class II",
        "detection_limit": "2 ng/mL",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Elecsys Vitamin D Assay",
        "measurand": "Total 25-hydroxyvitamin D (25-OH vitamin D)",
        "panel": "Clinical Chemistry (75)"
    },
    "K173887.txt": {
        "device_name": "cobas CT/NG",
        "intended_use": "The cobas CT/NG on the cobas 6800/8800 system is an automated, qualitative in vitro nucleic acid diagnostic test, that utilizes real-time polymerase chain reaction (PCR), for the direct detection of Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) DNA in male and female urine, clinician-instructed self-collected vaginal swab specimens (collected in a clinical setting), clinician-collected vaginal swab specimens, and endocervical swab specimens, all collected in cobas PCR Media (Roche Molecular Systems, Inc.), and cervical specimens collected in PreservCyt solution.",
        "device_type": "Nucleic acid extraction, purification and amplification assay (real-time polymerase chain reaction)",
        "analytical_specificity": "The cobas CT/NG assay detects the known serovars of CT and 43 strains of NG.",
        "classification": "Class II",
        "detection_limit": "The analytical sensitivity (Limit of Detection or LoD) of the cobas CT/NG Test for use on the cobas 6800/8800 Systems was determined by analyzing a dilution series of quantified cultures of Chlamydia trachomatis (serovars D and I) and Neisseria gonorrhoeae isolates 2948 (ATCC 19424) and 891.",
        "assay_cut_off": "An assay cut-off of Ct value = 50, where 50 is the last PCR profile cycle, was established for the cobas CT/NG for use on the cobas 6800/8800 Systems.",
        "predicate_device_name": "cobas CT/NG v2.0 Test",
        "measurand": "Chlamydia trachomatis and Neisseria gonorrhoeae DNA"
    },
    "K162895.txt": {
        "device_name": "Elecsys Troponin T Gen 5 STAT Immunoassay",
        "intended_use": "Immunoassay for the in vitro quantitative determination of cardiac troponin T (cTnT) in lithium heparin plasma.  The immunoassay is intended to aid in the diagnosis of myocardial infarction.",
        "device_type": "Quantitative immunoassay",
        "analytical_specificity": "The potentially interfering compounds, at the following concentrations, did not interfere with the performance of the device (i.e., did not result in bias >10%).",
        "classification": "Class II",
        "detection_limit": "The measuring range of the assay is 6 \u2013 10000 ng/L and is defined by the LoQ at the low end and the linearity at the high end.",
        "assay_cut_off": "Not applicable.  See section 4 \u201cClinical cut-off\u201d.",
        "predicate_device_name": "Elecsys Troponin T STAT Assay",
        "measurand": "Cardiac troponin T (cTnT)"
    },
    "K180264.txt": {
        "device_name": "Gold Standard Diagnostics Borrelia burgdorferi IgG/IgM ELISA Test Kit",
        "intended_use": "The Gold Standard Diagnostics Borrelia burgdorferi IgG/IgM ELISA Test Kit is intended as a qualitative presumptive (first-step) test for the detection of IgG and IgM antibodies to B. burgdorferi sensu stricto in human serum from symptomatic patients or people suspected of infection.",
        "device_type": "Enzyme Immunoassay",
        "analytical_specificity": "97.3%",
        "classification": "Class II",
        "detection_limit": "N/A",
        "assay_cut_off": "\u22651.10",
        "predicate_device_name": "Trinity Biotech Captia Borrelia burgdorferi IgG/IgM ELISA Test Kit",
        "measurand": "Anti-Borrelia burgdorferi (IgM and IgG) antibodies",
        "panel": "Microbiology"
    },
    "K160682.txt": {
        "device_name": "CONTOUR NEXT ONE Blood Glucose Monitoring System",
        "intended_use": "The Contour Next ONE blood glucose monitoring system is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood drawn from the fingertips or palm.",
        "device_type": "Blood glucose test system, over the counter",
        "analytical_specificity": "Analytical specificity was assessed for twenty three endogenous and exogenous substances with two venous blood samples with two levels of glucose (approximately 80mg/dL and 300mg/dL).",
        "classification": "Class II",
        "detection_limit": "See linearity study in Section M1b above.",
        "assay_cut_off": "Not applicable.",
        "predicate_device_name": "CONTOUR NEXT USB Blood Glucose Meter",
        "measurand": "Glucose in fresh capillary whole blood from the fingertip and palm.",
        "panel": "75, Clinical Chemistry"
    },
    "K181092.txt": {
        "device_name": "CHROMID CARBA agar",
        "intended_use": "the qualitative detection and presumptive identification of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in rectal swab specimens from patients at risk of colonization",
        "device_type": "Selective, differential chromogenic culture medium",
        "analytical_specificity": "E. coli and K. pneumoniae with carbapenemases other than KPC-type carbapenemase may exhibit pink-burgundy or blue-green/blue-grey colonies on CHROMID CARBA agar",
        "classification": "Class II",
        "detection_limit": "1.5 x 10^3 CFU/mL",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "bioM\u00e9rieux CHROMID VRE agar",
        "measurand": "Colonies of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae",
        "panel": "83: Microbiology"
    },
    "K170464.txt": {
        "device_name": "StatStrip Xpress Blood Glucose Monitoring System",
        "intended_use": "The StatStrip Xpress Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood obtained from the fingertip.",
        "device_type": "Quantitative, amperometric assay (Glucose Oxidase)",
        "analytical_specificity": "Potential interference from some common endogenous and exogenous substances was established in k132121. The following information has been added to the outer carton labeling: \u201cEliminates interferences from common medicines such as Ibuprofen, Acetaminophen, and Vitamin C.\u201d",
        "classification": "Class II",
        "detection_limit": "See the linearity study in Section M.1.b. above.",
        "assay_cut_off": "Not applicable.",
        "predicate_device_name": "StatStrip Xpress Blood Glucose Monitoring System",
        "measurand": "Fresh capillary whole blood glucose from the fingertip",
        "panel": "Clinical Chemistry (75)"
    },
    "K150041.txt": {
        "device_name": "CORA System",
        "intended_use": "in vitro diagnostic use to provide semi-quantitative indications of the hemostasis state of a blood sample",
        "device_type": "Multipurpose system for in vitro coagulation studies",
        "analytical_specificity": "The Kaolin with Heparinase assay was tested to validate that 6 IU of Heparinase per 1 mL of blood (the amount of Heparinase in the CKH assay) will effectively neutralize the effects of both Unfractionated Heparin (UFH) and Low Molecular Weight Heparin (LMWH) on Kaolin-activated citrated whole blood samples",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Thromboelastograph Coagualtion Analyzer (TEG)-5000 Series, Haemoscope Corporation",
        "measurand": "Coagulation factors (intrinsic and extrinsic pathway) and platelet aggregation",
        "panel": "Hematology (81)"
    },
    "K181043.txt": {
        "device_name": "Nova StatStrip Glucose Hospital Meter System",
        "intended_use": "The StatStrip Glucose Hospital Meter System is intended for point-of-care, in vitro diagnostic, multiple-patient use for the quantitative determination of glucose in capillary finger stick, venous whole blood, arterial whole blood, neonate arterial whole blood and neonate heel stick specimens throughout all hospital and all professional healthcare settings including patients receiving intensive medical intervention/therapy.",
        "device_type": "Glucose Test System",
        "analytical_specificity": "Potential interference from common endogenous and exogenous substances, as well as in vivo interference, was evaluated in k060345 and k132121.",
        "classification": "II",
        "detection_limit": "This range was verified by the linearity established in k063821; section M.1.b.",
        "assay_cut_off": "Not Applicable.",
        "predicate_device_name": "Nova StatStrip Glucose Hospital Meter System",
        "measurand": "Capillary whole blood glucose"
    },
    "K161714.txt": {
        "device_name": "Immunalysis Barbiturates Urine Enzyme Immunoassay",
        "intended_use": "The Immunalysis Barbiturates Urine Enzyme Immunoassay is a homogeneous enzyme immunoassay with a cutoff of 200 ng/mL. The assay is intended for use in laboratories for the qualitative and semi-quantitative analysis of Barbiturates in human urine with automated clinical chemistry analyzers.",
        "device_type": "Homogenous Enzyme Immunoassay, Qualitative and Semi-quantitative",
        "analytical_specificity": "The sponsor performed cross-reactivity studies in both qualitative and semi-quantitative modes by spiking various barbiturates or structurally related compounds into drug free urine at levels that will yield a result that is equivalent to the assay cutoff (200 ng/mL).",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "200 ng/mL",
        "predicate_device_name": "DRI Barbiturates EIA Assay",
        "measurand": "Barbiturates",
        "panel": "Toxicology (91)"
    },
    "K142965.txt": {
        "device_name": "VirtuosoTM System for IHC PR (1E2) Using the VENTANA iScan HT",
        "intended_use": "The VirtuosoTM system provides automated digital slide creation, management, analysis, and viewing. It is intended for in vitro diagnostic use as an aid to the pathologist in the display, detection, counting, review and classification of tissues and cells of clinical interest based on particular morphology, color, intensity, size, pattern and shape.",
        "device_type": "Automated Digital Image Manual Interpretation Microscope",
        "analytical_specificity": "The accuracy of the VirtuosoTM System for IHC PR (1E2) using the VENTANA iScan HT was evaluated by comparing the IHC PR score agreement between the reference manual method (MR) using a traditional microscope and the DR application of the Virtuoso system.",
        "classification": "Class II",
        "detection_limit": "\u22651% cut-off",
        "assay_cut_off": "\u22651% cut-off",
        "predicate_device_name": "Virtuoso\u2122 System for IHC PR (1E2), k111869",
        "measurand": "progesterone receptor (PR) protein",
        "panel": "Pathology (88)"
    },
    "K181889.txt": {
        "device_name": "Liofilchem MTS, Penicillin",
        "intended_use": "The Liofilchem MTS (MIC Test Strip) Penicillin 0.002-32 \u03bcg/mL is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of bacteria.",
        "device_type": "Quantitative Antimicrobial Susceptibility Test growth-based detection",
        "analytical_specificity": "Not Applicable",
        "classification": "II",
        "detection_limit": "Not Applicable",
        "assay_cut_off": "Not Applicable",
        "predicate_device_name": "Liofilchem MTS, vancomycin",
        "measurand": "Penicillin 0.002-32 \u03bcg/mL",
        "panel": "83 \u2013 Microbiology"
    },
    "K181288.txt": {
        "device_name": "Athelas One",
        "intended_use": "quantitative determination of white blood cells (WBC) and Neutrophil percentages (NEUT%) in capillary or K2EDTA venous whole blood",
        "device_type": "Automated cell counter system",
        "analytical_specificity": "The interference study results demonstrated that the following interferents do not interfere with test results up to the following concentrations: Triglyceride Rich Lipoproteins 500 mg/dL, Hemolysate 500 mg/dL, Protein 8 g/dL, Levodopa 20 mg/L, Methyldopa 71 \u00b5mol/L, Metronidazole 701 \u00b5mol/L, Acetylsalicyclic Acid 3.62 mmol/L, Phenylbutazone 400 mg/L, Rifampicin 78.1 \u00b5mol/L, Cyclosporine 5 mg/L, Acetaminophen 1324 \u00b5mol/L, Heparin 3000 U/L, Ibuprofen 2425 \u00b5mol/L, Bilirubin C 5 mg/dL, Bilirubin F 15 mg/dL",
        "classification": "Class II",
        "detection_limit": "WBC: 0.079 x103/\u00b5L, LoQ: 0.440 x103/\u00b5L",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Sysmex XE-5000 Automated Hematology Analyzer",
        "measurand": "White blood cell count (WBC) and percent neutrophil count (NEUT%)",
        "panel": "Hematology (81)"
    },
    "K183462.txt": {
        "device_name": "Applied Biosystems Bacillus anthracis Detection Kit",
        "intended_use": "The Applied Biosystems Bacillus anthracis Detection Kit is a real-time polymerase chain reaction (PCR) test kit intended for the qualitative in vitro diagnostic (IVD) detection of target DNA sequences for Bacillus anthracis (B. anthracis, or BA).",
        "device_type": "Real-time polymerase chain reaction (PCR) test kit",
        "analytical_specificity": "The exclusivity of the Applied Biosystems Bacillus anthracis Detection Kit was evaluated by testing a panel of non-target microorganisms, including near-neighbors and other bacteria, viruses and fungi that might be present in blood specimens or may cause infections with a similar clinical presentation to those patients suspected of anthrax.",
        "classification": "Class II",
        "detection_limit": "The LoD of the Applied Biosystems Bacillus anthracis Detection Kit was then confirmed by testing 60 replicates at the estimated LoD (20 replicates for each of three test kit lots). The final LoD for each specimen type and extraction method was determined to be the lowest concentration of B. anthracis that generated \u2265 95% detection.",
        "assay_cut_off": "Ct values that are <38 for both the pX01 and pX02 targets will generate a \u201cBacillus anthracis detected\u201d result. A sample may result as \u201cBacillus anthracis suspected\u201d if one of the two BA targets is not detected, or if one or both BA targets results in a Ct value \u2265 38 but less than 40.",
        "predicate_device_name": "FilmArray NGDS Warrior Panel",
        "measurand": "Nucleic acid sequences of Bacillus anthracis pX01 and pX02 plasmids",
        "panel": "83- Microbiology"
    },
    "K180936.txt": {
        "device_name": "ETEST Telavancin",
        "intended_use": "ETEST is a quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria such as Enterobacteriaceae, Pseudomonas, Staphylococcus, and Enterococcus species and fastidious bacteria, such as anaerobes, N. gonorrhoeae, S. pneumoniae, Streptococcus and Haemophilus species.",
        "device_type": "Quantitative AST growth-based detection",
        "analytical_specificity": "Not applicable",
        "classification": "II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "ETEST Ceftaroline",
        "measurand": "Telavancin 0.002 \u2013 32 \u00b5g/mL",
        "panel": "83 \u2013Microbiology"
    },
    "K143329.txt": {
        "device_name": "AmpliVue Trichomonas Assay",
        "intended_use": "The AmpliVue Trichomonas Assay is an in vitro diagnostic test, uses isothermal amplification technology (helicase-dependent amplification, HDA) for the qualitative detection of Trichomonas vaginalis nucleic acids isolated from clinician-collected vaginal swab specimens obtained from symptomatic or asymptomatic females to aid in the diagnosis of trichomoniasis.",
        "device_type": "Nucleic acid amplification assay (Helicase-dependent Amplification, HDA)",
        "analytical_specificity": "No cross-reactivity was observed with the AmpliVue Trichomonas Assay when testing any of the 45 microorganisms.",
        "classification": "Class II",
        "detection_limit": "The assay LoD for T. vaginalis strain G3 is 307 trophozoites/mL and for strain CDC888 is 921 trophozoites/mL.",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "APTIMA Trichomonas vaginalis Assay (PANTHER System)",
        "measurand": "A conserved multi-copy sequence of Trichomonas vaginalis genomic DNA",
        "panel": "83 - Microbiology"
    },
    "K181379.txt": {
        "device_name": "H. PYLORI QUIK CHEK",
        "intended_use": "The TECHLAB H. PYLORI QUIK CHEK test is a rapid membrane enzyme immunoassay for the qualitative detection of Helicobacter pylori specific antigen in a single use cassette.",
        "device_type": "Qualitative membrane enzyme immunoassay",
        "analytical_specificity": "The H. PYLORI QUIK CHEK test was evaluated for cross-reactivity with the bacteria, fungi, and viruses listed below.",
        "classification": "Class I",
        "detection_limit": "16.1 ng/mL",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "ImmunoCard STAT! HpSA",
        "measurand": "H. pylori antigen",
        "panel": "83-Microbiology"
    },
    "K190219.txt": {
        "device_name": "Simplexa VZV Direct assay",
        "intended_use": "for the qualitative detection of varicella-zoster virus (VZV) DNA in cerebrospinal fluid (CSF) from patients with signs and/or symptoms of meningitis and/or encephalitis",
        "device_type": "real-time polymerase chain reaction (PCR) system",
        "analytical_specificity": "100% homology with the exception of Genbank KU52949, which showed 99% homology with one mismatch in the Taqman probe region",
        "classification": "Class II",
        "detection_limit": "1.505 logs copies/mL",
        "assay_cut_off": "Cycle Threshold (Ct) values observed in the optical channels for VZV and the Internal Control targets to previously determined cut-offs",
        "predicate_device_name": "FilmArray Meningitis/Encephalitis (ME) Panel",
        "measurand": "DNA from varicella zoster virus"
    },
    "K151265.txt": {
        "device_name": "SD GlucoNFC Blood Glucose Monitoring System",
        "intended_use": "quantitative measurement of glucose (sugar) in fresh capillary whole blood from fingertip, palm, forearm or upper arm",
        "device_type": "over-the-counter and prescription blood glucose monitoring systems",
        "analytical_specificity": "no significant interference was detected at the following concentrations: acetaminophen \u2265 6 mg/dL, ascorbic acid \u2265 4 mg/dL, uric acid \u2265 5 mg/dL, and xylose \u2265 30 mg/dL",
        "classification": "Class II",
        "detection_limit": "20-600 mg/dL",
        "assay_cut_off": "not applicable",
        "predicate_device_name": "SD GlucoMentor BGMS",
        "measurand": "Capillary whole blood glucose from fingertip, palm, forearm, or upper arm",
        "panel": "Chemistry"
    },
    "K181700.txt": {
        "device_name": "HardyDisk AST Plazomicin 30\u00b5g (PLZ30)",
        "intended_use": "HardyDisk AST Disks are used for semi-quantitative in vitro susceptibility testing by the agar diffusion test procedure (Kirby-Bauer) of rapidly growing and certain fastidious bacterial pathogens.",
        "device_type": "Antimicrobial Susceptibility Test Disks",
        "analytical_specificity": "Not applicable",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "HardyDisk Tigecycline 15\u00b5g",
        "measurand": "Plazomicin 30\u00b5g",
        "panel": "83, Microbiology"
    },
    "K171971.txt": {
        "device_name": "skyla Clinical Chemistry Analyzer, Minicare C300 Clinical Chemistry Analyzer",
        "intended_use": "The Comprehensive Metabolic Panel is intended to be used for the quantitative determination of Alkaline Phosphate (ALP), Alanine Aminotransferase (ALP/GPT), Aspartate Aminotransferase (AST/GOT), Blood Urea Nitrogen (BUN) and Creatinine (CREA) in concentrations in lithium-heparinized venous whole blood, heparinized plasma, or serum in a clinical laboratory setting or point-of-care location.",
        "device_type": "Analyzer, chemistry, centrifugal, for clinical use",
        "analytical_specificity": "To determine the effects of potential endogenous and exogenous interference, the sponsor conducted an analytical specificity study according to CLSI EP07-A2 guideline.",
        "classification": "Class II",
        "detection_limit": "The limit of blank (LoB), limit of detection (LoD), and limit of quantitation (LoQ) were determined according to CLSI EP17-A2 guideline.",
        "assay_cut_off": "Not applicable.",
        "predicate_device_name": "Abaxis Piccolo, Abaxis Piccolo Primary Health Panel Reagent Rotor",
        "measurand": "Alkaline phosphate (ALP), Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Blood urea nitrogen (BUN) and Creatinine (CREA)"
    },
    "K173829.txt": {
        "device_name": "NeoLSD MSMS kit",
        "intended_use": "The NeoLSD MSMS Kit is intended for the quantitative measurement of the activity of the enzymes acid-\u03b2-glucocerebrosidase (ABG), acid-sphingomyelinase (ASM), acid-\u03b1-glucosidase (GAA), \u03b2-galactocerebrosidase (GALC), \u03b1-galactosidase A (GLA), and \u03b1-L-iduronidase (IDUA) in dried blood spots (DBS) from newborn babies.",
        "device_type": "Assay Only Template",
        "analytical_specificity": "The potential interfering substances for possible mass overlaps was assessed by searching two mass spectrometry databases, NIST 14 and MassBank, and CLSI EP07-A2 for potential mass overlaps (\u00b11 Da of the target analytes) of the six enzymatic products and six internal standards.",
        "classification": "II",
        "detection_limit": "The Limit of Blank (LoB), Limit of Detection (LoD), and Limit and Quantitation (LoQ) for the test system was determined.",
        "assay_cut_off": "Not applicable.",
        "predicate_device_name": "SEEKER System",
        "measurand": "Acid-\u03b2-glucocerebrosidase (ABG), acid-sphingomyelinase (ASM), acid-\u03b1-glucosidase (GAA), \u03b2-galactocerebrosidase (GALC), \u03b1-galactosidase A (GLA), and \u03b1-L-iduronidase (IDUA)",
        "panel": "Chemistry (75)"
    },
    "K150168.txt": {
        "device_name": "Dimension Tacrolimus Flex Reagent Cartridge (TAC)",
        "intended_use": "The Dimension Tacrolimus Flex Reagent Cartridge (TAC) is an in vitro diagnostic test for the quantitative measurement of tacrolimus in human whole blood on the Dimension clinical chemistry system.",
        "device_type": "Immunoassay",
        "analytical_specificity": "No interference was observed with the exogenous compounds tested and a complete list of the compounds and results are tabulated in the package insert.",
        "classification": "Class II",
        "detection_limit": "0.5 ng/mL",
        "assay_cut_off": "Not applicable \u2013 this is a quantitative assay.",
        "predicate_device_name": "ARCHITECT Tacrolimus Assay",
        "measurand": "Tacrolimus",
        "panel": "Toxicology (91)"
    },
    "K173817.txt": {
        "device_name": "Liofilchem MIC Test Strip (MTS)",
        "intended_use": "The Liofilchem MIC Test Strip (MTS) is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of bacteria.",
        "device_type": "Quantitative Antimicrobial Susceptibility Test growth based detection",
        "analytical_specificity": "Not applicable",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Liofilchem MTS, Vancomycin",
        "measurand": "Ceftazidime/avibactam 0.016/4 \u2013 256/4 \u00b5g/mL",
        "panel": "Microbiology (83)"
    },
    "K150588.txt": {
        "device_name": "OVA1 Next Generation",
        "intended_use": "The OVA1 Next Generation test is a qualitative serum test that combines the results of five immunoassays into a single numeric result. It is indicated for women who meet the following criteria: over age 18, ovarian adnexal mass present for which surgery is planned, and not yet referred to an oncologist.",
        "device_type": "Software algorithm that combines five immunoassays into a single score",
        "analytical_specificity": "None of the interfering substances demonstrated significant interference on the OVA1 Next Generation score up to the concentrations evaluated.",
        "classification": "Class II",
        "detection_limit": "Apolipoprotein A-1 (APO): 0.03 g/L (1.07 \u03bcmol/L), CA 125 II: 0.600 IU/mL, Follicle Stimulating Hormone (FSH): 0.100 mIU/mL, Human epididymis protein 4 (HE4): LoB: 5.0 pmol/L, LoD: 15.0 pmol/L, LoQ: 20.0 pmol/L, Transferrin (TRF): 0.1 g/L (1.26 \u03bcmol/L)",
        "assay_cut_off": "Low probability of malignancy: OVA1 Next Generation risk score < 5.0, High probability of malignancy: OVA1 Next Generation risk score \u2265 5.0",
        "predicate_device_name": "Vermillion OVA1, K081754",
        "measurand": "Score based on 5 serum analytes",
        "panel": "Immunology (82)"
    },
    "K193024.txt": {
        "device_name": "Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Lefamulin",
        "intended_use": "clinical susceptibility testing of H. influenzae, Streptococcus pneumoniae, and Streptococcus spp.",
        "device_type": "in vitro diagnostic product",
        "analytical_specificity": "not applicable",
        "classification": "Class II",
        "detection_limit": "not applicable",
        "assay_cut_off": "not applicable",
        "predicate_device_name": "Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Omadacycline",
        "measurand": "Lefamulin in the dilution range of 0.008 \u2013 16 \u03bcg/mL",
        "panel": "96 well plate is dosed with selected antimicrobial agents and substrate for the fluorescent reads, then dried"
    },
    "K141114.txt": {
        "device_name": "BioPlex 2200 25-OH Vitamin D Kit",
        "intended_use": "The BioPlex 2200 25-OH Vitamin D kit is a flow competitive immunoassay intended for the quantitative determination of 25-hydroxyvitamin D in human serum.",
        "device_type": "Assay Only Template",
        "analytical_specificity": "The study was conducted using 2 serum pools at 25-hydroxyvitamin D concentrations of 20 ng/mL and 35 ng/mL.",
        "classification": "Chemistry (75)",
        "detection_limit": "The LoB, LoD, and LoQ are summarized below: LoB 0.8 ng/mL, LoD 2.5 ng/mL, LoQ 6.5 ng/mL",
        "assay_cut_off": "Not Applicable",
        "predicate_device_name": "EUROIMMUN 25-OH Vitamin D ELISA",
        "measurand": "25-hydroxyvitamin D [25(OH) Vitamin D]"
    },
    "K153683.txt": {
        "device_name": "Trak Male Fertility Testing System",
        "intended_use": "semi-quantitative assessment of sperm concentration at 15 million sperm per milliliter (M/mL) or below, between 15 and 55 M/mL, and above 55 M/mL",
        "device_type": "Counter, Differential Cell",
        "analytical_specificity": "The potential interference of various substances on Trak results was evaluated by testing elevated concentrations of saliva, urine, blood, leukocytes, E. coli, C. albicans, C. trachomatis, N. perflava, testosterone, D-norgestrel, and \u03b2-estradiol as interfering substances in the Trak test.",
        "classification": "Class II",
        "detection_limit": "low concentration samples were consistently assigned correctly into the \u226415 M/mL category, thereby meeting the specified acceptance criteria.",
        "assay_cut_off": "15 M/mL and 55 M/mL",
        "predicate_device_name": "SpermCheck Fertility",
        "measurand": "Sperm concentration",
        "panel": "Hematology (81)"
    },
    "K161217.txt": {
        "device_name": "VITEK 2 AST-Gram Negative Ceftriaxone",
        "intended_use": "The VITEK 2 Antimicrobial Susceptibility Test (AST) is intended to be used with the VITEK 2 Systems for the automated quantitative or qualitative susceptibility testing of isolated colonies for the most clinically significant aerobic gram-negative bacilli, Staphylococcus spp., Enterococcus spp., Streptococcus spp., S. pneumoniae and clinically significant yeast.",
        "device_type": "Automated quantitative or qualitative antimicrobial susceptibility test for Ceftriaxone",
        "analytical_specificity": "Not Applicable",
        "classification": "Class II",
        "detection_limit": "Not Applicable",
        "assay_cut_off": "Not Applicable",
        "predicate_device_name": "VITEK 2 AST-GN Doxycycline",
        "measurand": "The VITEK 2 AST-Gram Negative card contains the following concentrations of Ceftriaxone: 0.12, 0.25, 1, 4 and 16\u00b5g/mL (equivalent standard method concentration by efficacy in \u00b5g/mL). The MIC result reporting range for the card is \u2264 0.25 - \u226564 \u00b5g/mL.",
        "panel": "83 Microbiology"
    },
    "K182353.txt": {
        "device_name": "EliA CENP, EliA U1RNP, EliA RNP70",
        "intended_use": "in vitro semi-quantitative measurement of IgG antibodies directed to CENP, U1RNP, and RNP70 in human serum and plasma",
        "device_type": "Automated semi-quantitative solid-phase fluoroimmunoassays",
        "analytical_specificity": "fluorescence immunoassays for the detection and measurement of human antibodies",
        "classification": "Class II",
        "detection_limit": "0.4-0.9 EliA U/mL",
        "assay_cut_off": "< 7-10 EliA U/mL",
        "predicate_device_name": "EliA CENP on Phadia 250, EliA U1RNP on Phadia 250, EliA RNP70 on Phadia 250",
        "measurand": "IgG autoantibodies specific to Centromere protein (CENP), U1 ribonucleoprotein (U1RNP), and ribonucleoprotein 70kDa (RNP70)",
        "panel": "Immunology (82)"
    },
    "K162333.txt": {
        "device_name": "Wondfo One Step Fecal Occult Blood Test",
        "intended_use": "qualitative detection of human occult blood in feces as an aid in the diagnosis of gastrointestinal (GI) bleeding",
        "device_type": "Lateral flow chromatographic immunoassay",
        "analytical_specificity": "equivalently recognized variants of hemoglobin HbA, HbS and HbC",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "45 ng/mL (Human hemoglobin in human fecal sample mixed with detection buffer)",
        "predicate_device_name": "FOB One Step Rapid Test (Orient Gene Biotech)",
        "measurand": "Human hemoglobin (hHb) in feces",
        "panel": "Hematology (81)"
    },
    "K180607.txt": {
        "device_name": "KRONUS Steroid 21-Hydroxylase Autoantibody (21-OHAb) ELISA Kit",
        "intended_use": "The KRONUS Steroid 21-Hydroxylase Autoantibody (21-OHAb) ELISA Kit is for the qualitative determination of antibodies to steroid 21-hydroxylase (21-OH) in human serum.",
        "device_type": "ELISA Kit",
        "analytical_specificity": "The KRONUS 21-OHAb ELISA Kit depends on the divalent properties of the Steroid 21-Hydroxylase autoantibodies (21-OHAb) to form a bridge between 21-OH coated on ELISA plate wells and liquid phase 21-OH-biotin.",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "45",
        "predicate_device_name": "KRONUS 21-OHAb RIA Assay Kit",
        "measurand": "Steroid 21-Hydroxylase autoantibodies",
        "panel": "Immunology (82)"
    },
    "K173202.txt": {
        "device_name": "CP3000 Coagulation Analyzer",
        "intended_use": "The CP3000 is a fully automated, random-access in vitro blood coagulation analyzer intended for use by healthcare professionals in the clinical laboratory.",
        "device_type": "Device",
        "analytical_specificity": "The common endogenous and exogenous interfering substances and their interference results are listed below and showed no significant interference up to the indicated concentration for all tested citrated plasma samples.",
        "classification": "Class II",
        "detection_limit": "5%",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "ACL TOP 700 LAS",
        "measurand": "Antithrombin activity (%)",
        "panel": "Hematology (81)"
    },
    "K163260.txt": {
        "device_name": "SeptiCyte LAB",
        "intended_use": "To obtain a substantial equivalence determination for the SeptiCyte LAB",
        "device_type": "Gene expression assay using reverse transcription polymerase chain reaction",
        "analytical_specificity": "No interference was found for any of the substances in Table 4 and Table 5 at the concentration listed",
        "classification": "Class II (Special Controls)",
        "detection_limit": "0.273 X 10^6 WBC/mL blood",
        "assay_cut_off": "See clinical cut-off",
        "predicate_device_name": "B\u00b7R\u00b7A\u00b7H\u00b7M\u00b7S PCT Sensitive KRYPTOR",
        "measurand": "Four mRNA transcript immune biomarkers: LAMP1, CEACAM4, PLA2G7, PLAC8",
        "panel": "83: Microbiology"
    },
    "K141689.txt": {
        "device_name": "FastPack High Sensitivity C-Reactive Protein Immunoassay",
        "intended_use": "evaluation of conditions thought to be associated with inflammation, in otherwise healthy individuals",
        "device_type": "Quantitative",
        "analytical_specificity": "No interference found at the below tested concentrations: Bilirubin (conjugated) up to 40 mg/dL, Bilirubin (unconjugated) up to 40 mg/dL, Hemoglobin up to 750 mg/dL, Lipids up to 1000 mg/dL, Human serum albumin up to 7.7 g/dL, Transferrin up to 567 mg/dL, Human IgG up to 2961 \u03bcg/mL",
        "classification": "Class II",
        "detection_limit": "0.063 mg/L CRP",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Olympus CRP Latex Reagent, Bio-Rad Laboratories Liquichek Cardiac Markers Plus Control, Ortho-Clinical Diagnostics, Inc. VITRO Chemistry Products hsCRP Performance Verifier, I, II, and III",
        "measurand": "C-reactive protein (CRP)",
        "panel": "Clinical Chemistry"
    },
    "K182513.txt": {
        "device_name": "FluChip-8G Influenza A+B Assay",
        "intended_use": "The FluChip-8G Influenza A+B Assay is a multiplex RT-PCR in vitro diagnostic test intended for the qualitative detection and differentiation of seasonal influenza A/H3N2, seasonal influenza A/H1N1pdm09, and \u201cnon-seasonal\u201d influenza A subtypes other than seasonal H1N1pdm09 or H3N2. The assay is also intended for the qualitative detection and differentiation of the genetic lineage of human influenza B viruses as B/Victoria or B/Yamagata.",
        "device_type": "Molecular Assay System",
        "analytical_specificity": "The FC8G assay was executed on either titered stock whole virus or extracted RNA (depending on subtype) spiked into pooled clinical negative material at close to the LoD concentration. Each strain was tested in triplicate. Any virus that was not correctly identified in triplicate was tested again at a higher concentration until detected.",
        "classification": "Class II",
        "detection_limit": "The limit of detection (LoD) was determined for each FC8G assay target virus group (influenza A/H3N2, influenza A/H1N1pdm2009, influenza B/Yamagata, influenza B/Victoria, and non-seasonal influenza A) by testing serial dilutions of stock virus strains (used either as intact virus or viral genomic RNA, depending on influenza subtype) spiked into pooled influenza negative clinical material.",
        "assay_cut_off": "The assay cutoff was determined for each FC8G assay target virus group (influenza A/H3N2, influenza A/H1N1pdm2009, influenza B/Yamagata, influenza B/Victoria, and non-seasonal influenza A) by testing serial dilutions of stock virus strains (used either as intact virus or viral genomic RNA, depending on influenza subtype) spiked into pooled influenza negative clinical material.",
        "predicate_device_name": "CDC Human Influenza Virus Real-Time PCR Diagnostic Panel",
        "measurand": "Influenza RNA",
        "panel": "Microbiology (83)"
    },
    "K161258.txt": {
        "device_name": "NOVA Lite DAPI ANCA (Ethanol) Kit",
        "intended_use": "qualitative detection and semi-quantitative determination of anti-neutrophil cytoplasmic antibodies (ANCA) of IgG isotypes in human serum",
        "device_type": "indirect immunofluorescence assay",
        "analytical_specificity": "no interference was detected with the tested substances, up to the maximal concentrations indicated above",
        "classification": "Class II",
        "detection_limit": "not applicable",
        "assay_cut_off": "20 LIU for NOVA Lite DAPI ANCA (Ethanol) Kit and 30 LIU for NOVA Lite DAPI ANCA (Formalin) Kit",
        "predicate_device_name": "NOVA Lite ANCA",
        "measurand": "Anti-Neutrophil Cytoplasmic Antibodies (ANCA)",
        "panel": "Immunology (82)"
    },
    "K161619.txt": {
        "device_name": "Xpert TV Assay",
        "intended_use": "aid in the diagnosis of trichomoniasis in symptomatic or asymptomatic individuals",
        "device_type": "nucleic acid amplification test using real-time polymerase chain reaction (PCR)",
        "analytical_specificity": "The presence of seminal fluid did not interfere with detection of Trichomonas vaginalis in the Xpert Trichomonas Assay.",
        "classification": "Class II",
        "detection_limit": "Limit of detection studies were previously reviewed and described in K151565.",
        "assay_cut_off": "The studies determining the assay cut-off were previously reviewed and described in K151565.",
        "predicate_device_name": "Cepheid Xpert TV assay",
        "measurand": "Trichomonas vaginalis (TV) DNA"
    },
    "K150526.txt": {
        "device_name": "Optilite IgG4 Kit",
        "intended_use": "The quantitative in vitro measurement of IgG4 in serum using the Binding Site Optilite analyser.",
        "device_type": "Quantitative, turbidimetric",
        "analytical_specificity": "No significant assay interference effects were observed when the five samples were tested with bilirubin at 200mg/L, hemoglobin at 5g/L, or triglyceride at 1000mg/dL.",
        "classification": "Class II",
        "detection_limit": "0.299mg/L",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Binding Site Human IgG and IgG subclass (IgG1, IgG2, IgG3, IgG4) liquid reagent kits for use on the SPAplus",
        "measurand": "IgG4 subclass Antibody",
        "panel": "Immunology (82)"
    },
    "K171974.txt": {
        "device_name": "Solana RSV+hMPV Assay",
        "intended_use": "The Solana RSV+hMPV Assay is a qualitative in vitro diagnostic test for the detection and differentiation of RSV and hMPV viral RNA in nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection.",
        "device_type": "Respiratory Viral Panel Multiplex Nucleic Acid Assay",
        "analytical_specificity": "The Solana RSV+hMPV Assay was evaluated for potential cross-reactivity (false positive results) with organisms that may be found in the nasal passages of patients with symptoms of respiratory tract infection.",
        "classification": "Class II",
        "detection_limit": "7.9x10^3 TCID50/mL for RSV A, 3.9x10^2 TCID50/mL for RSV B, 3.7x10^2 TCID50/mL for hMPV Type A1, 1.2x10^4 TCID50/mL for hMPV Type A2, 3.8x10^3 TCID50/mL for hMPV Type B1, and 2.3x10^3 TCID50/mL for hMPV Type B2",
        "assay_cut_off": "The preliminary threshold settings for the Solana RSV+hMPV Assay were determined during the development stage and were based on the analysis of the fluorescent signal obtained with known positive and negative clinical specimens, as well as analysis of contrived samples used in the determination of LoD.",
        "predicate_device_name": "Lyra RSV+hMPV Assay",
        "measurand": "RSV RNA: Matrix Gene, hMPV RNA: Fusion Protein Gene",
        "panel": "Microbiology (83)"
    },
    "K160585.txt": {
        "device_name": "XN CAL",
        "intended_use": "calibration and calibration verification of Sysmex XN series hematology analyzers",
        "device_type": "Calibrator for cell indices",
        "analytical_specificity": "Not applicable",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "XN CAL",
        "measurand": "Assayed hematology parameters:  WBC (103/\u03bcL), RBC (106/\u03bcL), HGB (g/dL), HCT (%), PLT (103/\u03bcL), and RET (%)",
        "panel": "Hematology (81)"
    },
    "K180209.txt": {
        "device_name": "Diazyme 1,5-AG Assay",
        "intended_use": "The intermediate term monitoring of glycemic control in people with diabetes",
        "device_type": "Assay, 1,5-Anhydroglucitol",
        "analytical_specificity": "The following substances were tested up to the levels indicated and demonstrated no significant interference:",
        "classification": "Class II",
        "detection_limit": "0.45 ug/mL",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "GlycoMark",
        "measurand": "1,5-Anhydroglucitol (1,5-AG)",
        "panel": "Hematology (81)"
    },
    "K143502.txt": {
        "device_name": "Immunalysis Opiates Urine Enzyme Immunoassay",
        "intended_use": "For the qualitative and semi-quantitative determination of the presence of opiates in human urine at a cutoff of 300 ng/mL and 2000 ng/mL",
        "device_type": "Analytical Reagents",
        "analytical_specificity": "The assay is based on the competition of opiates labeled enzyme glucose-6-phosphate dehydrogenase (G6PDH) and the free drug in the urine sample for the fixed amount of antibody binding sites",
        "classification": "II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "300 ng/mL and 2000 ng/mL",
        "predicate_device_name": "DRI DAU Opiate Assay",
        "measurand": "Opiates",
        "panel": "DLJ\u2013 Clinical Toxicology"
    },
    "K163626.txt": {
        "device_name": "ARIES Bordetella Assay",
        "intended_use": "The ARIES Bordetella Assay is a real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection and identification of Bordetella pertussis (B. pertussis) and Bordetella parapertussis (B. parapertussis) nucleic acid in nasopharyngeal swab (NPS) specimens obtained from individuals suspected of having a respiratory tract infection attributable to B. pertussis or B. parapertussis.",
        "device_type": "Qualitative real-time polymerase chain reaction",
        "analytical_specificity": "The ARIES Bordetella Assay is specific for the detection of B. pertussis and B. parapertussis, and does not cross-react with other microorganisms.",
        "classification": "Class II",
        "detection_limit": "The analytical LoD was confirmed using the final assay protocol file parameters (i.e. cut-off values). The final LoD concentrations for the four strains of Bordetella are shown in Table 5 below. The overall assay LoD for B. pertussis is 1800 CFU/mL and B. parapertussis is 213 CFU/mL.",
        "assay_cut_off": "Each target in the ARIES Bordetella assay (B. pertussis and B. parapertussis) has a Ct cut-off, Tm window, and Tm Peak Threshold.",
        "predicate_device_name": "illumigene Pertussis DNA Amplification Assay (Meridian Bioscience, Inc.)",
        "measurand": "Bordetella pertussis toxin promoter, Bordetella parapertussis IS1001 insertion element in respective genomes",
        "panel": "Microbiology (83)"
    },
    "K173505.txt": {
        "device_name": "FORA GTel Blood Glucose Monitoring System",
        "intended_use": "FORA GTel Blood Glucose Monitoring System is intended for use in the quantitative measurement of glucose in fresh capillary whole blood drawn from the finger. It is intended for in vitro diagnostic use by people with diabetes mellitus at home as an aid in monitoring the effectiveness of diabetes control program.",
        "device_type": "Blood Glucose Monitoring System",
        "analytical_specificity": "Potential interfering substances were evaluated at three glucose concentration intervals (61, 119, and 264 mg/dL) by analyzing 39 potentially interfering exogenous and endogenous substances.",
        "classification": "Class II",
        "detection_limit": "20-600 mg/dL",
        "assay_cut_off": "Not Applicable",
        "predicate_device_name": "FORA GD43 Blood Glucose Monitoring System",
        "measurand": "Capillary whole blood glucose from the fingertip",
        "panel": "Clinical Chemistry (75)"
    },
    "K182357.txt": {
        "device_name": "HardyDisk AST Eravacycline 20\u00b5g (ERV20)",
        "intended_use": "HardyDisk AST Disks are used for semi-quantitative in vitro susceptibility testing by the agar diffusion test procedure (Kirby-Bauer) of rapidly growing and certain fastidious bacterial pathogens.",
        "device_type": "Antimicrobial Susceptibility Test Disks",
        "analytical_specificity": "Not applicable",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "HardyDisk Tigecycline 15\u00b5g",
        "measurand": "Eravacycline 20\u00b5g"
    },
    "K143075.txt": {
        "device_name": "ST AIA-PACK SHBG",
        "intended_use": "quantitative measurement of sex hormone binding globulin (SHBG) in human serum or Na heparinized plasma on Tosoh AIA System Analyzers",
        "device_type": "In Vitro Diagnostic Use Only",
        "analytical_specificity": "cross reactivity to structurally similar endogenous steroids with the ST AIA-PACK SHBG assay was determined by spiking human serum samples with each compound and comparing the SHBG results to a control sample spiked with an equivalent volume of sample diluting solution",
        "classification": "Class I, reserved",
        "detection_limit": "0.017 nmol/L",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Architect SHBG Reagent Kit",
        "measurand": "Sex Hormone Binding Globulin (SHBG)",
        "panel": "Clinical Chemistry (75)"
    },
    "K150815.txt": {
        "device_name": "BD FACSPresto System",
        "intended_use": "Instrument and Device",
        "device_type": "Automated multicolor fluorescent imaging cytometer and absorbance spectrometer",
        "analytical_specificity": "The endogenous and exogenous interference studies were performed in accordance with CLSI EP07-A2 guidelines.",
        "classification": "Class II (assay) and Class II (controls)",
        "detection_limit": "22 cells/\u00b5L for CD4 assay and 0.91 g/dL for Hemoglobin assay",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "BD FACSCalibur using BD Tritest CD3/CD4/CD45 with BD Trucount Tubes and Sysmex Automated Hematology Analyzer KX-21N",
        "measurand": "Lymphocyte CD4 absolute count, CD4 percentage of lymphocytes, and hemoglobin concentration"
    },
    "K152386.txt": {
        "device_name": "NxTAG Respiratory Pathogen Panel",
        "intended_use": "qualitative test intended for use on the Luminex MAGPIX Instrument for the simultaneous detection and identification of nucleic acids from multiple respiratory viruses and bacteria extracted from nasopharyngeal swabs collected from individuals with clinical signs and symptoms of a respiratory tract infection",
        "device_type": "multiplex real time RT-PCR",
        "analytical_specificity": "broad coverage of all the analytes detected in the NxTAG RPP assay",
        "classification": "Class II",
        "detection_limit": "the lowest concentration at which \u226595% (\u226519/20) of samples tested generated positive calls",
        "assay_cut_off": "the established (final) cut-off values for each analyte are listed in Table 41",
        "predicate_device_name": "BioFire Diagnostics, LLC FilmArray Respiratory Panel",
        "measurand": "Influenza A RNA, Influenza B RNA, RSV A and RSV B, Coronaviruses 229E, OC43 and NL63 RNA, Coronavirus HKU1 RNA, Human Metapneumovirus RNA, Rhinovirus/Enterovirus RNA, Adenovirus DNA, Parainfluenza virus RNA, Human Bocavirus DNA, Chlamydophila pneumoniae DNA, and Mycoplasma pneumoniae DNA",
        "panel": "Microbiology (83)"
    },
    "K170293.txt": {
        "device_name": "Emit II Plus Cocaine Metabolite Assay",
        "intended_use": "The Emit II Plus Cocaine Metabolite Assay is a homogeneous enzyme immunoassay with a 150 ng/mL or 300 ng/mL cutoff. The assay is intended for use in the qualitative and semiquantitative analyses of benzoylecgonine (cocaine metabolite) in human urine.",
        "device_type": "Qualitative and semi-quantitative homogenous enzyme immunoassay",
        "analytical_specificity": "For analytical specificity please reference k993988. Additional structurally related compounds were evaluated by spiking each of the drugs indicated in the tables below into drug free urine, and determining the lowest concentration that produces a response equivalent to benzoylecgonine at each device cutoff.",
        "classification": "Class II",
        "detection_limit": "Not Applicable",
        "assay_cut_off": "Characterization of how the device performs analytically around the claimed cutoff concentrations of 150 ng/mL and 300 ng/mL is described in the precision section, M.1.a. above",
        "predicate_device_name": "Emit II Plus Cocaine Metabolite Assay",
        "measurand": "Benzoylecgonine",
        "panel": "DIO \u2013 Cocaine and cocaine metabolic test system"
    },
    "K182922.txt": {
        "device_name": "Liofilchem MTS Omadacycline 0.002-32 \u03bcg/mL",
        "intended_use": "The Liofilchem MTS (MIC Test Strip) Omadacycline 0.002-32 \u03bcg/mL is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of bacteria.",
        "device_type": "Quantitative Antimicrobial Susceptibility Test growth-based detection",
        "analytical_specificity": "Not Applicable",
        "classification": "II",
        "detection_limit": "Not Applicable",
        "assay_cut_off": "Not Applicable",
        "predicate_device_name": "Liofilchem MTS, vancomycin",
        "measurand": "Omadacycline 0.002-32 \u03bcg/mL",
        "panel": "83 \u2013 Microbiology"
    },
    "K150281.txt": {
        "device_name": "StatStrip Glucose Hospital Meter System",
        "intended_use": "The StatStrip Glucose Hospital Meter System is intended for point-of-care, in vitro diagnostic, multiple-patient use for the quantitative determination of glucose in capillary finger stick, venous whole blood, arterial whole blood, neonate arterial whole blood and neonate heel stick specimens.",
        "device_type": "Glucose test system",
        "analytical_specificity": "Potential interference from common endogenous and exogenous substances, as well as in vivo interference, was evaluated in k060345 and k132121.",
        "classification": "Class II",
        "detection_limit": "10 to 600 mg/dL",
        "assay_cut_off": "Not Applicable",
        "predicate_device_name": "Nova StatStrip Glucose Hospital Meter System",
        "measurand": "Capillary whole blood glucose, venous, arterial, neonate arterial, and neonate heelstick samples",
        "panel": "Clinical Chemistry (75)"
    },
    "K161831.txt": {
        "device_name": "IDS-iSYS 25VitDS assay",
        "intended_use": "The IDS-iSYS 25 VitDS  Assay is intended for the quantitative determination  of  total   25-hydroxyvitamin  D  [(25(OH)D]  in human  serum  or  plasma  on  the  IDS-iSYS   Multi-Discipline Automated System.",
        "device_type": "Vitamin D Test System",
        "analytical_specificity": "The IDS-iSYS 25VitDS assay is traceable to the Ghent University isotope dilution-liquid chromatography/tandem mass spectrometry (ID-LCMS/MS) 25(OH)D Reference Method Procedure (RMP).",
        "classification": "Class II",
        "detection_limit": "1.31 ng/mL",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "IDS-iSYS 25-Hydroxy Vitamin DS Assay",
        "measurand": "Total 25-hydroxyvitamin D",
        "panel": "Clinical Chemistry (75)"
    },
    "K172287.txt": {
        "device_name": "QIAGEN ipsogen JAK2 RGQ PCR Kit",
        "intended_use": "The ipsogen JAK2 RGQ PCR Kit is a qualitative in vitro diagnostic test for the detection of the JAK2 V617F/G1849T allele in genomic DNA extracted from EDTA whole blood.",
        "device_type": "Allele-specific, quantitative, polymerase chain reaction (PCR) using an amplification refractory mutation system (ARMS)",
        "analytical_specificity": "The overall agreement is 96.8% (458/473 subjects; 95% CI: [94.8%; 98.2%])",
        "classification": "Class II",
        "detection_limit": "1%",
        "assay_cut_off": "1%",
        "predicate_device_name": "ipsogen JAK2 RGQ PCR Kit",
        "measurand": "Janus Tyrosine Kinase 2 (JAK2) gene mutation G1849T (V617F)",
        "panel": "88 \u2013 Pathology"
    },
    "K170974.txt": {
        "device_name": "BD FACSLyric Flow Cytometer",
        "intended_use": "in vitro diagnostic device for immunophenotyping using up to six fluorescence detection channels and two light scatter channels using a blue (488-nm) and a red (640-nm) laser",
        "device_type": "Flow Cytometer",
        "analytical_specificity": "Quantitative and Semi-quantitative Flow Cytometric Immunoassays",
        "classification": "Class II",
        "detection_limit": "less than 15 cells/\u03bcL",
        "assay_cut_off": "200 cells/\u03bcL",
        "predicate_device_name": "BD FACSCanto II",
        "measurand": "Lymphocyte subset percentages and absolute counts",
        "panel": "Hematology (81)"
    },
    "K151917.txt": {
        "device_name": "ARIES System",
        "intended_use": "in vitro diagnostic (IVD) platform that performs nucleic acid based tests in clinical laboratories",
        "device_type": "clinical multiplex test system",
        "analytical_specificity": "nucleic-acid amplification testing",
        "classification": "Class II (special controls)",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "BD MAX System",
        "measurand": "nucleic acid sequences",
        "panel": "Chemistry (75)"
    },
    "K162526.txt": {
        "device_name": "Creatine Kinase-MB assay",
        "intended_use": "The Creatine Kinase-MB assay is an in vitro test for the quantitative determination of the catalytic activity of creatine kinase MB subunit (CK-MB) in human serum and plasma on Roche/Hitachi cobas c systems.",
        "device_type": "Quantitative, enzymatic assay",
        "analytical_specificity": "Endogenous interference: The effects of interference by hemoglobin, lipemia (Intralipid), and bilirubin on the CK-MB test system was determined on the cobas c 501 analyzer using pooled human serum samples with 2 CK-MB levels (Level 1: ~18 U/L, Level 2: ~1180 U/L) and spiked with varying levels of interferent.",
        "classification": "Class II",
        "detection_limit": "The Limit of Blank (LoB) was determined as the 95th percentile of measurements of blank samples. The LoB calculation was performed with one analyte-free sample measured in 10 replicates with 3 reagent lots over 6 runs, 3 days, and on one cobas c 501 analyzer.",
        "assay_cut_off": "Not applicable",
        "predicate_device_name": "Roche CK-MB",
        "measurand": "Creatine kinase MB subunit",
        "panel": "Clinical Chemistry (75)"
    },
    "K193393.txt": {
        "device_name": "BOND Ready-to-Use Primary Antibody Progesterone Receptor (16), Novocastra Liquid Mouse Monoclonal Antibody Progesterone Receptor Clone 16",
        "intended_use": "Qualitative identification of human Progesterone Receptor in breast cancer patients",
        "device_type": "Immunohistochemistry reagents and kits",
        "analytical_specificity": "Analytical specificity and interference studies were provided in the original 510k notification. Please refer to K062615 for more details.",
        "classification": "Class II",
        "detection_limit": "Not applicable",
        "assay_cut_off": "Scoring: Test results are considered as positive when \u22651% of tumor nuclei are immunoreactive (positive staining) for progesterone receptor and negative when <1% of tumor cells are immunoreactive for progesterone receptor.",
        "predicate_device_name": "BOND Ready-to-Use Primary Antibody Progesterone Receptor (16), Novocastra Liquid Mouse Monoclonal Antibody Progesterone Receptor Clone 16",
        "measurand": "Human Progesterone Receptor in formalin-fixed, paraffin embedded breast cancer tissue",
        "panel": "Immunohistochemistry"
    }
}